Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
streetinsider.com » StreetInsider.com News Articles - Aug 26, 2010
Netezza (NYSE: NZ) 15.3% HIGHER; reports Q2 non-GAAP EPS of $0.09, 3 cents better than the analyst estimate of $0.06. Revenue for the quarter was $6.8 million, which compares to the estimate of $53.93 million. J. Crew …
Also tagged: dell, hpq, nz, bebe, ovti, jcg, lava, par, mcrs, iflg, dllr, qadi
streetinsider.com » StreetInsider.com News Articles - Aug 26, 2010
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Immunomedics+%28IMMU%29+reports+Q4+EPS+of+1c/5927215.html for the full story.
seekingalpha.com » US Market Commentary from Seeking Alpha - Jul 15, 2010
Steve Alexander submits: No metric is more loved on Wall Street than revenue growth rates. The pace of revenue growth is usually a major factor in the valuation assigned to a given company. Analysts routinely …
Also tagged: s, amed, prsc, clwr, gxdx, afam, céu, solr, cski, drwi, magicdiligence, jgbo ob
seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Jul 12, 2010
Michael Becker submits: Monoclonal antibodies, which have been approved for immunological, anti-infective, ophthalmic, cancer and other categories, represent one of the most successful therapeutic drug classes. Ten …
Also tagged: dna, amgn, miti, sgen, nbi, regn, hgsi, alxn, rhhby pk, imgn, michael becker, mphsf pk, gnmsf pk
seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Jun 21, 2010
Zacks.com submits: Recently, Immunomedics Inc. (IMMU) and its Belgian partner UCB presented encouraging data from a mid-stage study of their lupus drug candidate epratuzumab at the European League Against Rheumatism …
Also tagged: zacks com
streetinsider.com » StreetInsider.com News Articles - Jun 9, 2010
Shuffle Master (Nasdaq: SHFL) 8.4% HIGHER; reports Q2 EPS of $0.15, 5 cents better than the analyst estimate of $0.10. Revenue for the quarter was $50.8 million, which compares to the estimate of $47.64 million …
seekingalpha.com » Financial Sector and Stocks Analysis from Seeking Alpha - May 17, 2010
First Coverage submits: click to enlarge Up Week for Market Ends on Sour Note Complete Story »
Also tagged: ep, zinc, spf, atvi, erts, sks, v, mtb, pcx, first coverage
istockanalyst.com » Home: iStockAnalyst.com Feed - Mar 22, 2010
“It is our opinion, along with that of many other market professionals, that this current market is overbought. An overbought market often searches for a place, or more to the point, a reason to pull back.[More...]
Also tagged: tech, endp, mrk, abt, jnj, pfe, amgn, unh, cypb, aet, osi, crxl, drrx, arna, sgmo, zmh, teva, wcrx, wlp, ceph, alth, miti, celg, isis, onxx, bcs, frx, gild, nbix, osip, vnda, lly, auxl, thrx, bmy, acor, stem, mdco, gern, alxa, sqnm, vrtx, esrx, blk, affx, mhs, bmrn, orex, siga, prgo, agn, amln, osir, mygn, itmn, fds, aria, sgen, svnt, ghdx, biib, genz, shpgy, trgt, nbi, pdli, alny, dndn, nabi, bcrx, nvax, xoma, hti, bjgp, dva, dgx, dsco, qgen, hum, nktr, ilmn, vphm, snts, enzn, flml, bmti, alks, slxp, xnpt, exel, zgen, lgnd, mdv, gtxi, ci, ompi, snta, optr, cbrx, regn, lmnx, mnta, qlti, adlr, gpro, pard, hgsi, myl, sppi, dyax, cbst, isph, endo, alxn, cra, idix, uthr, ptie, supg, crme, pozn, mnkd, arry, maxy, npsp, hitk, pgnx, vvus, incy, vicl, cytk, vrus, arql, biod, depo, imgn, mdvn, lxrx, amag, cadx, dmi, rigl, ipxl, qsc, akrx, amri, nnyp, cski
streetinsider.com » StreetInsider.com News Articles - Feb 2, 2010
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Immunomedics+%28IMMU%29+Reports+Q2+EPS+of+%240.01/5297636.html for the full story.
seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Nov 2, 2009
EP Vantage submits: The high hopes that both the market and sufferers from lupus hold for Human Genome Sciences' (HGSI) lead drug, Benlysta, showed no signs of being dashed Monday after the group and partner …
Also tagged: gsk, hgsi, ep vantage